Access cutting-edge multiple myeloma treatment through this clinical trial at a research site in Detroit. Study-provided care at no cost to qualified participants.
Access multiple myeloma specialists in Detroit at no cost
This study follows strict safety protocols and ethical guidelines
All study-related multiple myeloma treatment provided free
This phase II trial studies the effects of leflunomide in treating African-American and European-American patients with high-risk smoldering multiple myeloma. Leflunomide is used to decrease the body's immune response and may delay the symptoms of multiple myeloma in patients of African-American and European decent.
Sponsor: City of Hope Medical Center
Check if you qualify for this multiple myeloma clinical trial in Detroit, MI
If you're searching for multiple myeloma treatment options in Detroit, MI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Detroit research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple myeloma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.